It is generally upregulated in laryngeal cancer, gastric cancer, ovarian cancer, etc.185–188 And tumor gene expression profiling analysis also confirmed that FOXM1 is one of the most frequently upregulated genes in human malignant tumors,189 so it has become an important target for drug development. This evidence concerns the gene FOXM1 and cancer.